Retrospective multicenter analysis of real-life toxicity and outcome of ipilimumab and nivolumab in metastatic uveal melanoma
Ipi + nivo shows moderate efficacy and clinically relevant toxicities in patients with MUM. Eosinophilia is a potential prognostic biomarker, that merits further investigation.
Authors
- Egle Ramelyte (ORCID: https://orcid.org/0000-0001-8262-8608)
- Christoffer Gebhardt (ORCID: https://orcid.org/0000-0001-7090-9584)
- Amélie Ciernik (ORCID: https://orcid.org/0009-0003-4444-4412)
- Julian Kött (ORCID: https://orcid.org/0000-0003-2073-3909)
- Monika Morak (ORCID: https://orcid.org/0000-0003-0809-8404)
- Thomas J. Carter (ORCID: https://orcid.org/0000-0001-5940-0146)
- Samuel Tschopp (ORCID: https://orcid.org/0000-0002-5666-2092)
- Paul Nathan (ORCID: https://orcid.org/0000-0002-2327-3250)
- Ryan J. Sullivan (ORCID: https://orcid.org/0000-0001-5540-6962)
- Reinhard Dummer (ORCID: https://orcid.org/0000-0002-2279-6906)
- Aleigha Lawless (ORCID: https://orcid.org/0009-0009-3861-3164)
- Laure Ciernik (ORCID: https://orcid.org/0009-0005-4501-243X)
- Lucie Heinzerling (ORCID: https://orcid.org/0000-0001-5718-3643)
- Peter Bonczkowitz
- Yacine Bennaceur
Institutions
- Harvard University (US)
- Universität Hamburg (DE)
- University of Zurich (CH)
- Academy of Fine Arts Karlsruhe (DE)
- Massachusetts General Hospital (US)
- University Hospital of Zurich (CH)
- University Medical Center Hamburg-Eppendorf (DE)
- Mount Vernon Cancer Centre (GB)
- University Cancer Center Hamburg (DE)
- Center for Cancer Research (US)
- Technische Universität Berlin (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1093/oncolo/oyaf173
- Citations
- 4
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.83